[1] 国家药典委员会.中华人民共和国临床用药须知[M]:2010 年版.化学药和生物制品卷. 835-836. [2] Liaw Y F, Gane E, Leung N, et al. 2-Year GLOBE trial results:telbivudine Is superior to lamivudine in patients with chronic hepatitis B[J]. Gastroenterology, 2009,136(2):486-95. [3] Lai C L, Gane E, Liaw Y F, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B[J]. N Engl J Med, 2007,357(25):2576-88. [4] 蔡告东.替比替定相关性肌酸激酶升高与肌病及其安全应用[J].药物不良反应杂志,2009(4):253-256. [5] Zhang X S, Jin R,Zhang S B,et al.Clincial features of advers reactions assoiated with telbivudine[J].World J Gastroenterol,2008,14(22):3549-3553. [6] Sathavivam S,Lecky B.Statin induced myopathy[J].BMJ,2008,337:a2286. |